Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Q.2 (Alpha)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Q.2 (Alpha)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BL.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
M.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
M.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.66NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.66NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.485NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.485NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.177.73NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.73NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.112.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.112.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.36NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BV.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BV.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.33NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CP.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CQ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.13NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CC.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.129 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.129 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XAY.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used